Santa Clara, Calif.’s AutekBio, a Silicon Valley-Beijing hybrid that grows engineered cell lines for drug companies, raised $1.1 million. See our story in today’s daily briefing at VentureBeat Life Sciences.
Trackback URL
Top Stories
- Facebook hands classifieds service to Oodle
- The Huffington Post confirms $25M third round
- A new, elaborate $20 billion deal for ...
- Mobile ad spending rises as iPhone effect ...
- Joost is loosed on the iPhone. Looks ...
Recent Guest Columnists
Job Board
- Regional Vice President of Sales
at Marketing Technology Solutions (Jersey City, NJ) - More Jobs » | Post a Job »
Links
Venturebeat Writers
- Matt Marshall, Editor-in-Chief
- Dean Takahashi, Lead Writer, DigitalMedia
- Eric Eldon, Editor, DigitalMedia
- MG Siegler, Writer, DigitalMedia
- Anthony Ha, Writer, VentureBeat
- Chris Morrison, Writer, CleanTech
- For advertising, contact .
- Log in
Font Size
© 2004-2008(c) Matt Marshall. All rights reserved.Site produced by RubyRed Labs, Evan Levelle
powered by Wordpress